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We cannot expect the United States and the
United Kingdom to shoulder the entire financial
burden of global NTD control. The world’s
emerging market economies and the nations of the
Gulf Cooperation Council must now step up and
share this commitment.
Writer, columnist, and Newsweek Interna-
tional Editor Fareed Zakaria has coined the
term ‘‘the post-American world’’ to refer
to a new world order that has unfolded
over the last decade [1]. Briefly stated, the
United States became the world’s most
powerful nation beginning in the 20th
century, and since the fall of communism
we have lived in a world in which the US
is the only superpower. However, the last
few years have witnessed what Zakaria
calls the ‘‘rise of the rest,’’ referring to
massive economic growth in what we
ordinarily refer to as developing countries.
He points out that 124 countries grew at a
rate of 4% or higher in 2006 and 2007 [1].
While much of this growth can be
attributed to the so-called BRIC emerging
economies, i.e., Brazil, Russia, India, and
China, as well as other Asian nations, the
economies of at least 30 African countries
also increased, and in all, poverty has been
falling among 80% of the world’s popula-
tion, including Indonesia, Kenya, and
South Africa [1]. Indeed, with the excep-
tion of about 50 truly devastated nations,
there has been general global growth
throughout the low- and middle-income
countries of Africa, Asia, and the Americas
[1].
World Bank President Robert Zoellick
has echoed similar sentiments. In an April
2010 address, he made the statement that
2009 saw the end of what was known as
the ‘‘Third World’’ [2]. According to Mr.
Zoelick, Asia’s stock markets now account
for a larger share of global market
capitalization than those of the United
States or Europe. He further states that
‘‘this change is not just about China and
India’’ [2]. Instead, what we used to call
the developing world’s share of global
GDP in purchasing power parity is
approaching 50%, while India, Bangla-
desh, and sub-Saharan Africa, where most
of the ‘‘bottom billion’’ (i.e., the world’s
poorest people surviving below the World
Bank poverty level of US$1.25 per day)
live, are each expected to grow by an
average of over 6%–7% annually for at
least the next five years [2]. Together, the
Southeast Asian countries of Vietnam,
Thailand, and Malaysia have gone from
being a low-income region to becoming a
powerful group of middle-income coun-
tries with important links to India and
China [2]. Some of this economic growth
is being fueled by the Middle East, which
has become an important source of global
capital. Today, the sovereign wealth fund
assets of the Gulf Cooperation Council
countries, meaning Kuwait, Bahrain,
Saudi Arabia, Qatar, United Arab Emir-
ates, and Oman, are estimated to be
approximately US$1 trillion [2]. As a
result, the influence of the G8, as well as
other European countries, is evaporating
in favor of a larger group of G20
countries, which includes Brazil, Mexico,
China, Korea, Saudi Arabia, India, In-
donesia, and South Africa (Figure 1).
Not everyone agrees with such global
economic assessments, including the an-
thropologist Thayer Scudder, who points
to evidence suggesting the overall decline
of global living standards [3]. But if
Zakaria and Zoellick are correct, I believe
their assessments and predictions of geo-
political and economic transformations in
the developing world could soon have
important implications for the global
control of the neglected tropical diseases
(NTDs). The NTDs are the most common
infections of the world’s poor, especially
the bottom billion [4]. Most are chronic
and disabling parasitic infections such as
the intestinal helminth infections, schisto-
somiasis, lymphatic filariasis, food-borne
trematode infections, and onchocerciasis,
as well as selected bacterial and viral
infections such as trachoma and dengue
[4,5]. A key feature of the NTDs is their
ability to exacerbate poverty by impairing
child development, pregnancy outcome,
and agricultural worker productivity (evi-
dence reviewed in reference [4]). Another
feature of the NTDs is their dispropor-
tionate impact on Islamic nations and
rogue nuclear states, and therefore the
areas of geopolitical interest to the US and
Europe [6–9].
In response to the growing awareness of
the importance of NTDs as a global health
and security threat, the US government,
through its Agency for International
Development (USAID), and to some
extent the British Department for Inter-
national Development (DFID), have be-
gun to provide up to US$100 million
annually for NTD control, with plans to
possibly double this amount by 2011 [10].
Additional funds for global parasite con-
trol have been provided to the government
of Japan through its Hashimoto Initiative
[11]. While these dollar amounts pale in
comparison to the funds allocated for
HIV/AIDS through the President’s Emer-
gency Plan for AIDS Relief, the truth is
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little as US$0.50 annually, it is possible to
provide mass drug administration to
support the seven most common NTDs
and those producing the highest disease
burden [4,5,10]. Therefore, even the
modest funds allocated to date may be
sufficient to treat 200–400 million people
annually, or roughly one-quarter of the
bottom billion who urgently need treat-
ments. In addition, ongoing support will
be needed for sanitation, clean, water, and
the overall strengthening of health systems
[12–14].
Which countries should step up to treat
theremainderoftheworld’spopulationthat
urgently needs access to essential NTD
medicines? Sadly, the G8 countries, other
than the US, UK, and Japan, have largely
ignored the NTD problem. For instance,
the Italian government, which through its
Ministry of Foreign Affairs held a high
profile NTD workshop in Rome in 2009
[15], has so far failed to translate the
conclusions of this meeting into meaningful
action; similarly, the German government,
whose major pharmaceutical companies,
Bayer Schering and Merck KgaA, devel-
oped praziquantel inthe 1970s, has failed to
find a mechanism by which to establish an
urgently needed public–private partnership
inorderfullydonate thisdesperatelyneeded
drug for Africa [16]. In addition, the richest
non-G8Europeancountries havealsofailed
to support global NTD control. This failure
is in stark contract to companies such as
Merck & Co.,GlaxoSmithKline,Johnson &
Johnson, and Pfizer, which donate ivermec-
tin, albendazole, mebednazole, and azith-
romycin, respectively [5]. While certainly
the European governments are distracted
by their own recent economic downturns,
such as the recent fall of the euro and
economic assistance for Greece [17], it is
now clear that the disease-endemic coun-
tries must identify new funding partners for
NTD development assistance.
Instead, in this new post-American
world order, there is a fresh (and unprec-
edented) opportunity for some of the
highest disease burden countries to look
to what we used to call the developing
world and 28 so-called emerging markets
(Boxes 1 and 2). New investments from the
former Third World need to happen at
multiple levels. First, the BRIC countries
almost certainly can afford mass drug
therapeutic approaches for their own
indigenous NTDs. Based on their NTD
disease burden [8,19], if the BRIC coun-
tries would take responsibility for their
own control and elimination efforts, then
roughly 20% of the world’s burden of
intestinal helminth infections, lymphatic
filariasis, and trachoma could be reduced.
In addition, the emerging market nations
of Nigeria and Indonesia exhibit some of
the highest NTD disease burdens in Africa
and Southeast Asia, respectively [20,21]. If
together the BRIC countries and Nigeria
and Indonesia would commit to control-
ling their own NTDs, it would likely
double the impact of the current US
commitment.
Some of these same BRIC countries
must also provide development assistance
in the form of NTD control and elimina-
tion efforts for the African and Asian
countries where they now heavily invest in
mining, oil and gas explorations, and other
activities with high economic return rates.
By some estimates, Chinese investments in
Africa are growing by 50% annually, and
Beijing is aggressively pursuing Africa’s oil,
natural gas, and other reserves it requires
in order to sustain growth in China [1].
According to Zakaria, at a 2006 summit
held in Beijing attended by all 48 African
countries, the largest number of African
leaders assembled outside the continent,
China promised to provide US$5 billion in
loans and credits and another US$5 billion
to encourage ongoing investments in the
African continent [1]. Undoubtedly, some
of these funds will further stimulate
Africa’s growing economy, but as Zakaria
points out, in exchange for access to
natural resources, China has entered into
questionable agreements with the Mugabe
regime in Zimbabwe and the Bashir
regime in Sudan [1]. At a May 17, 2010
Ministerial Working Group on Scaling Up
of Primary Health Systems held in Geneva
and organized by Professor Jeffrey Sachs
and the Earth Institute at Columbia
University, I had the opportunity to meet
with Dr. Chen Zhu, the Minister of Health
of China, and remind him that China has
an unrivaled success in NTD control,
having been the first country to success-
Figure 1. The emerging market economies. From Wikimedia Commons. Available: http://
commons.wikimedia.org/wiki/File:Developed_and_Emerging_markets.png. Accessed July 21, 2010.
doi:10.1371/journal.pntd.0000812.g001
Box 1. The Emerging Market
Economies [18]
Brazil
Chile
China
Colombia
Czech Republic
Egypt
Hungary
India
Indonesia
Malaysia
Mexico
Morocco
Nigeria
Peru
Philippines
Poland
Russia
South Africa
South Korea
Taiwan
Thailand
Turkey
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make enormous progress in reducing its
burden of Asian schistosomiasis [5,21,22].
There is now a moral and ethical imper-
ative for China to take the lead in
transferring its NTD control and elimina-
tion know-how and provide support for
NTD control in sub-Saharan Africa.
Given the billions of dollars China invests
annually in Africa, it certainly can afford a
comparatively modest investment in NTD
control, one that is at least equivalent to
the USAID commitment.
In addition to private philanthropic
investments, the final 20% of NTD control
c a nc o m ef r o mt h eM i d d l eE a s t .I na
previous paper I pointed out that almost
one-half of the world’s NTDs occur in the
member nations of the Organisation of the
Islamic Conference (OIC), i.e., the world’s
Islamic countries [23]. In addition to
Indonesia and Nigeria, the nations of
Bangladesh, Chad, Mali, Niger, Somalia,
Sudan, and Yemen are among the OIC
countries with the highest NTD burden
[23]. With the sovereign wealth funds of the
Gulf Cooperation Council countries exceed-
ing US$1 trillion [1], there is no reason why
annually 0.01% of this dollar amount—
US$100 million—cannot be devoted to
NTD control for the poorest OIC countries.
Of course, money alone will not ensure
global control and elimination of the
NTDs. As new funds become available,
there will be a need for appropriate
financial mechanisms in order to target
them for national NTD control programs;
these include bilateral arrangements with
health ministries in disease-endemic coun-
tries, and regional platforms and funds for
the Americas, Africa, and Asia, respec-
tively, as proposed by the Global Network
for NTDs [10]. In addition, for some
NTDs, there will be additional require-
ments to develop new drugs, vaccines, and
diagnostics and then to fold these new
control tools into national programs for
NTD control and existing health systems
[24,25]. The major needs for research and
development were outlined in a 2010
‘‘manifesto’’ document for the NTDs
[25], and recently the Dutch Ministry of
Foreign Affairs made an important com-
mitment to support research and develop-
ment for new NTD drugs and vaccines
[26]. Increasingly, there is also a global
demand to strengthen health systems in
parallel with support for neglected diseases
[25,27,28]. However, there is now a
desperate need for new financial support
to complement current NTD control and
elimination efforts by the governments of
the US and UK. Today, the BRIC
countries, Nigeria, Indonesia, and other
emerging market economies, as well as the
wealthy Gulf Cooperation Council nations
in the Middle East, must agree to take on
this challenge.
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